For instance, GlaxoSmithKline, in July 2017, received U.S.FDA approval for the subcutaneous
form of its biologic drug belimumab for treatment of systemic lupus erythematosus. Clinical
guidelines to include biologics in the treatment of systemic lupus erythematosus would further
aid in market growth. Multidisciplinary group consisting international experts in various
branches such as internal medicine, rheumatology, nephrology, dermatology, pediatrics, and
cardiology published recommendations in journal Autoimmune Review in 2017, for the use of
biologics in patients with systemic lupus erythematosus, according to which biologic drugs such
as abatacept, rituximab, or tocilizumab can be used after evaluating patient profile.
However, cost associated with the treatment of systemic lupus erythematosus is high, which
makes the treatment unaffordable. Biological drugs are covered under Medi Claim, however,
unfavorable reimbursement scenario for new drugs and biologics may limit adoption of these
drugs, which is expected to adversely affect the market growth.
Report includes chapters which deeply display the following deliverable about industry :
• Systemic Lupus Erythematosus Treatment Market Research Objective and Assumption
• Systemic Lupus Erythematosus Treatment Market Purview - Report Description, Executive
Summary, and Coherent Opportunity Map (COM)
• Systemic Lupus Erythematosus Treatment Market Dynamics, Regulations, and Trends Analysis -
Market Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system
Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Systemic Lupus Erythematosus Treatment Market, By Regions
• Systemic Lupus Erythematosus Treatment Market Competition by Manufacturers including
Production, Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and
Product Type.
• Systemic Lupus Erythematosus Treatment Market Manufacturers Profiles/Analysis including
Company Basic Information, Manufacturing Base and Its Competitors.
• Systemic Lupus Erythematosus Treatment Market Manufacturing Cost Analysis including Key
Raw Materials and Key Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market
Positioning and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Systemic Lupus Erythematosus Treatment Market Forecast including Production, Consumption,
Import and Export Forecast by Type, Applications and Region.